BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24678898)

  • 21. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of One-Way Text Messaging on Attendance to Follow-Up Cervical Cancer Screening Among Human Papillomavirus-Positive Tanzanian Women (Connected2Care): Parallel-Group Randomized Controlled Trial.
    Linde DS; Andersen MS; Mwaiselage J; Manongi R; Kjaer SK; Rasch V
    J Med Internet Res; 2020 Apr; 22(4):e15863. PubMed ID: 32238335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of visual inspection performed by community health workers in cervical cancer screening.
    Driscoll SD; Tappen RM; Newman D; Voege-Harvey K
    Int J Gynaecol Obstet; 2018 Sep; 142(3):260-269. PubMed ID: 29788542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-stage cervical cancer screening: an alternative for resource-poor settings.
    Denny L; Kuhn L; Risi L; Richart RM; Pollack A; Lorincz A; Kostecki F; Wright TC
    Am J Obstet Gynecol; 2000 Aug; 183(2):383-8. PubMed ID: 10942474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening.
    Shah S; Montgomery H; Smith C; Madge S; Walker P; Evans H; Johnson M; Sabin C
    HIV Med; 2006 Jan; 7(1):46-52. PubMed ID: 16313292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of cervical-cancer screening in five developing countries.
    Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
    N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge, Belief and Practice of Cervical Cancer Screening and Prevention among Women of Taraba, North-East Nigeria.
    Rimande-Joel R; Ekenedo GO
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3291-3298. PubMed ID: 31759351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
    Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
    JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-visit approach of cervical cancer screening: see and treat in Indonesia.
    Vet JN; Kooijman JL; Henderson FC; Aziz FM; Purwoto G; Susanto H; Surya IG; Budiningsih S; Cornain S; Fleuren GJ; Trimbos JB; Peters AA
    Br J Cancer; 2012 Aug; 107(5):772-7. PubMed ID: 22850550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV-based cervical cancer screening in Nicaragua: from testing to treatment.
    Holme F; Maldonado F; Martinez-Granera OB; Rodriguez JM; Almendarez J; Slavkovsky R; Bansil P; Thomson KA; Jeronimo J; de Sanjose S
    BMC Public Health; 2020 Apr; 20(1):495. PubMed ID: 32295562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
    Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
    Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of peer health education on perception and practice of screening for cervical cancer among urban residential women in south-east Nigeria: a before and after study.
    Mbachu C; Dim C; Ezeoke U
    BMC Womens Health; 2017 Jun; 17(1):41. PubMed ID: 28599635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
    Ogunbowale T; Lawoyin TO
    Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
    PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
    Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
    Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to follow-up after an abnormal cervical cancer screening result and the role of male partners: a qualitative study.
    Chapola J; Lee F; Bula A; Mapanje C; Phiri BR; Kamtuwange N; Tsidya M; Tang JH; Chinula L
    BMJ Open; 2021 Sep; 11(9):e049901. PubMed ID: 34521669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs of integrating cervical cancer screening at an HIV clinic in Kenya.
    Vodicka EL; Babigumira JB; Mann MR; Kosgei RJ; Lee F; Mugo NR; Okech TC; Sakr SR; Garrison LP; Chung MH
    Int J Gynaecol Obstet; 2017 Feb; 136(2):220-228. PubMed ID: 28099724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A population-based combination strategy to improve the cervical cancer screening coverage rate in Bamako, Mali.
    Téguété I; Tounkara FK; Diawara B; Traoré S; Koné D; Bagayogo A; Sissoko A; Traoré CB
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):794-801. PubMed ID: 33560520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.